or Try an Advanced Search...

    Genodermatoses Stocks List

    Symbol Grade Name % Change
    AZTR F Azitra Inc. -2.49
    OVID D Ovid Therapeutics Inc. 0.88
    INM D InMed Pharmaceuticals Inc. -2.03
    QNRX D Quoin Pharmaceuticals, Ltd. 1.51
    KRYS C Krystal Biotech, Inc. 2.24
    RCEL C Avita Medical Limited 1.98
    WVE B WAVE Life Sciences Ltd. 0.88
    KROS A Keros Therapeutics, Inc. 3.27
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Rare Diseases Epidermolysis Bullosa Clinical Medicine Medicine Netherton Syndrome Biopharmaceutical Dermatology Disorders Ichthyosis Organ Systems Syndromes Therapeutic Products Acid Aesthetics Anemia Anticonvulsants Biotechnology Biotherapeutic Products Bone Bone Disease

    Related ETFs - A few ETFs which own one or more of the above listed Genodermatoses stocks.

    Symbol Grade Name Weight
    SBIO B ALPS Medical Breakthroughs ETF 4.74
    HELX D Franklin Genomic Advancements ETF 4.25
    PSCH C PowerShares S&P SmallCap Health Care Portfolio 2.97
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 2.75
    JFWD A Jacob Funds Inc. Jacob Forward ETF 2.6
    View all Genodermatoses ETFs...
    Compare ETFs
    Compare PSCH to BBC Compare SBIO to JFWD Compare SBIO to PSCH

        Genodermatoses Stocks Recent News

        Date Stock Title
        Nov 1 KRYS Are Options Traders Betting on a Big Move in Krystal Biotech (KRYS) Stock?
        Oct 31 QNRX Quoin Pharmaceuticals to Announce Third Quarter 2024 Financial Results on Thursday, November 7, 2024
        Oct 31 OVID Ovid Therapeutics to Host Investor Event
        Oct 30 WVE Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
        Oct 29 WVE How to play biotech stocks: Insmed and Wave Life Sciences
        Oct 29 KRYS Will Apellis Pharmaceuticals, Inc. (APLS) Report Negative Earnings Next Week? What You Should Know
        Oct 29 AZTR Azitra to Present at BIO-Europe 2024
        Oct 28 KRYS Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
        Oct 28 WVE Wall Street Analysts Predict a 34.53% Upside in Wave Life Sciences (WVE): Here's What You Should Know
        Oct 28 INM InMed Pharmaceuticals Files Additional Patent Application for INM-901 in the Treatment of Neurodegenerative Conditions Including Alzheimer's Disease
        Oct 28 KRYS Krystal Biotech to Report Third Quarter 2024 Financial Results on November 4, 2024
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Rare Diseases Epidermolysis Bullosa Clinical Medicine Medicine Netherton Syndrome Biopharmaceutical Dermatology Disorders Ichthyosis Organ Systems Syndromes Therapeutic Products Acid Aesthetics Anemia Anticonvulsants Biotechnology Biotherapeutic Products Bone Bone Disease
        Genodermatoses

        Genodermatoses are inherited genetic skin conditions often grouped into three categories: chromosomal, single gene, and polygenetic.

        More about Genodermatoses
        Browse All Tags